Stephen D. Griffin insider trades

Open-market stock purchases and sales by Stephen D. Griffin, President and CEO at Anika Therapeutics, Inc, from SEC Form 4 filings since Nov 16, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +72%.

Recent trades

DateStockTradeValue
Jun 3, 2026ANIK Anika Therapeutics, IncSold (not open market)$54.3K
Jun 3, 2026ANIK Anika Therapeutics, IncBought (not open market)—
Apr 30, 2026ANIK Anika Therapeutics, IncBought$150K
Mar 14, 2026ANIK Anika Therapeutics, IncBought (not open market)—
Mar 14, 2026ANIK Anika Therapeutics, IncSold (not open market)$84.4K
Mar 14, 2026ANIK Anika Therapeutics, IncBought (not open market)—
Feb 1, 2026ANIK Anika Therapeutics, IncBought (not open market)—
Feb 1, 2026ANIK Anika Therapeutics, IncBought (not open market)—

Companies traded

  • ANIK Anika Therapeutics, Inc: 1 buy, last Jun 3, 2026
  • VSEC VSE Corp: other filings, last Apr 1, 2024

Get free alerts when Stephen D. Griffin files a new trade →